Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2005
12/14/2005EP1603558A1 Process for preparation of perindopril and salts thereof
12/14/2005EP1603554A1 Method for increasing the oral bioavailability of s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate
12/14/2005EP1603553A2 Pharmaceutical compositions of cetp inhibitors
12/14/2005EP1603551A2 Use of omega-3-fatty acids in the treatment of diabetic patients
12/14/2005EP1603545A2 Method of treatment of disease using an adenosine a1 receptor antagonist
12/14/2005EP1603543A1 Therapeutic compositions
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1527084A4 Promoters exhibiting endothelial cell specificity and methods of using same
12/14/2005EP1509228B1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
12/14/2005EP1450786B1 Isoflavone concentrate and method for production thereof
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1417189B1 Acylaminothiazole derivatives, their preparation and therapeutic use
12/14/2005EP1370144A4 Noninvasive measurements of chemical substances
12/14/2005EP1330428B1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1223931B1 Use of a imidazole derivative for the treatment or prevention of hypotension and shock
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005EP1178821B1 Use of anti-hbp antibodies in the inhibition of bradykinin release
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1007714B1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/14/2005CN1708491A N-benzodioxolyl, N-benzodioxanyl and N-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
12/14/2005CN1708480A Carotenoid analogs for the inhibition and amelioration of disease
12/14/2005CN1708308A Use of fosinopril to reduce cardiovascular events in dialysis patients
12/14/2005CN1708295A Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
12/14/2005CN1231589C Eukaryotic gene expression cassette and uses thereof
12/14/2005CN1231584C Cell proliferation factor Fwap 10576
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231474C Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents
12/14/2005CN1231473C Substituted arylpyrazines
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231469C Optically active amlodipine resolving process
12/14/2005CN1231466C New piperidine derivatives
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231261C Compound alliin enteric solubility capsule
12/14/2005CN1231230C Apoplexy treating capsule and its preparation method
12/14/2005CN1231225C Application of Artemisia sphaerocephala Krasch polysaccharide in preparation of antilipemic agent and health products
12/14/2005CN1231223C Breviscapine infusion preparation and its preparing method
12/14/2005CN1231222C Application of Funaosu in preventing and treating cadiovascular and cerebrovascular diseases
12/14/2005CN1231219C Huangyangning slow-releasing preparation
12/14/2005CN1231215C (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/13/2005US6974868 A 6-(7-((2-(phenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2, 3-triazolo(4,5-d)pyrimidin-3-yl)-tetrahydro-2,2-dimethyl-4H-cyclopentane-1,2-diol derivative; anticoagulants; myocardial infarction, strokes; thrombolytic and antiischemic agents;
12/13/2005US6974861 Conjestive heart failure; polypeptide
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974830 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974819 Alzheimer's disease; Parkinson's disease; Pick's disease; bipolar disorders; schizophrenia; alopecia; anticancer agents
12/13/2005US6974818 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
12/13/2005US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974809 Inhibitors of interleukin 1-β converting enzyme
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/13/2005US6974806 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion
12/13/2005US6974800 Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor
12/13/2005CA2271054C Substituted phenols and thiophenols useful as antioxidant agents
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116191A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor
12/08/2005WO2005115999A1 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115422A2 Compositions containing avocado leaf extract for lowering cholesterol levels
12/08/2005WO2005115409A1 Composition for inhibiting the onset of arteriosclerosis and inhibition method
12/08/2005WO2005115378A1 Compositions comprising flavonoids and tocotrienols and methods thereof
12/08/2005WO2005115377A1 Functional foods comprising flavonoids and tocotrienols and methods thereof
12/08/2005WO2005115366A1 Agent for preventing/amelioratig life style-relaetd diseases containing turmeric essential oil component
12/08/2005WO2005082860A8 Tetracyclines and their use as calpain inhibitors
12/08/2005WO2005074968A3 Medical use of basic peptides
12/08/2005WO2005054432A3 Gene transfer for regulating smooth muscle tone
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272813 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
12/08/2005US20050272806 Injectable formulations of taxanes for cad treatment
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272767 Method for treating myolytic disease and method for screening antimyolytic agent
12/08/2005US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272715 Optically active dihydropyridine derivative
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
12/08/2005US20050272701 Pharmaceutical composition
12/08/2005US20050272669 treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. -[(4-{3-[N-(Carbamoylmethyl)-N-(methanesulfonyl)amino]-propoxy}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole
12/08/2005US20050272634 for stimulating physiological mobilization, proliferation and differentiation of endothelial progenitor cells, vasculogenesis; diabetic wound healing
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
12/08/2005US20050272051 Methods of preventing or treating recurrence of myocardial infarction
12/08/2005US20050272036 Ketones
1 ... 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 ... 1595